A study in people with lower urinary tract symptoms.

Who can join: Adults 18 to 90, women only, have lower urinary tract symptoms, BMI 30+.
What you take: Check ClinicalTrials.gov for this trial's study groups and what each group receives.
How long it lasts: The full study runs about 2 years.
What you get: Costs vary by study. Ask the study team what this one covers, including the study medicine, visits and travel, before you sign the consent form.

This one may not fit you. We check your age, where you live, and the rules each study sets, then show the clinical trials that do.

Check my fit →

Phase Not ApplicableSponsor Hartford HealthCareDrug GLP1 receptor agonistClass OtherSites 1 USEnrollment target 200

What this study is for

Primary condition: Lower Urinary Tract Symptoms. Also studied in: Stress Urinary Incontinence, Urge Urinary Incontinence, Overactive Bladder, Pelvic Organ Prolapse, Weight Loss, Fecal Incontinence, Bariatric Surgery, glp1 Agonist.

Full scientific study title: Pelvic Floor Disorder Symptoms in Women Seeking Weight Loss Therapy.

Who can join

Age18 to 90SexFemaleBMI30 or higher

Adults 18 to 90, women only, have lower urinary tract symptoms, BMI 30+. A site coordinator confirms whether you qualify during a free screening visit. The exact medical requirements are below.

Full medical eligibility (for you and your doctor)verbatim from the registry

This is the exact wording from ClinicalTrials.gov, including clinical measures (lab values, imaging scores). Bring it to your doctor if any of it is unclear.

Key inclusion criteria

female
18-89 years old
any race/ethnicity
BMI ≥30 kg/m2
current medical weight loss or surgical weight loss patient of Obesity Medicine and Metabolic \& Bariatric Surgery

Key exclusion criteria

Pregnant
≥90 years old
\<18 years old
BMI \<30 kg/m2
A history of bariatric surgery prior to enrollment

Where this trial runs

This trial has 1 sites across 1 state. Site contacts are listed for reference. They are not screening through this trial right now.

Connecticut1 site

Hartford Hospital
Hartford, Connecticut
Madeline Carmain, MD860-972-4338madeline.carmain@hcchealth.org

Follow this trial

We email you if NCT07175805 changes status, adds new sites in your state, or if a similar trial opens for the same condition.

Timeline

Scheduled start: October 2025. Expected completion: June 2027. Last updated on ClinicalTrials.gov: September 16, 2025.

Official source

Every Monday we check this trial against ClinicalTrials.gov, the federal registry for clinical research. Last checked September 4, 2026. Confirm the current status there before you contact a site:

View on ClinicalTrials.gov →

Back to the full directory → or take the matching quiz if you want clinical trials filtered to your conditions and location.

John Samaras, Founder and EditorI started GLP Chart after overpaying for a GLP-1 myself. Based in Austin, Texas.
About this site LinkedIn Contact

Why you can trust GLP Chart. Same scoring framework applied to every program. No paid placements. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.